Literature DB >> 28077695

Stability Studies on Dry Swabs and Wet Mailed Swabs for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Aptima Assays.

Jeanne Moncada1, Carey B Clark2, Jeffrey Holden3, Edward W Hook2, Charlotte A Gaydos3, Julius Schachter4.   

Abstract

The Aptima Combo 2 (AC2) and Aptima CT (ACT) (Hologic Inc., San Diego, CA) are nucleic acid amplification tests (NAATs) that detect Chlamydia trachomatis AC2 also detects Neisseria gonorrhoeae Storage and temperature conditions may impact the utility of NAATs in some settings and screening programs. We evaluated specimen stability for use beyond the Aptima package insert specifications for temperature and duration of storage (between 2°C and 30°C and 60 days, respectively) in two studies: (i) dry C. trachomatis-seeded swabs were used with ACT after storage at 4°C, 23°C, or 36°C for up to 84 days and (ii) swabs seeded with C. trachomatis and N. gonorrhoeae and then placed in transport medium were tested with AC2, after being mailed via the U.S. Postal Service to three different sites. Prolonged storage of samples had no effect, and samples stored at 4°C, 23°C, and 36°C for up to 84 days yielded comparable ACT positivities, although there was a drop in signal intensity for virtually all specimens under all storage/shipping conditions after day 21. In the mailing study, 80%, 52% and 29% of seeded swabs were exposed to temperatures of >30°C during three rounds in transit, and 2% reached temperatures of >40°C. No evidence of signal degradation in the AC2 assay for detection of C. trachomatis or N. gonorrhoeae was observed, although some mailed swabs took more than 5 weeks to reach the laboratory site. These two studies support the potential use of swabs at temperatures above 36°C and storage beyond 60 days and provide confidence regarding this commercially available NAAT for testing of specimens after mailing.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Chlamydia trachomatis; Neisseria gonorrhoeae; detection; nucleic acid amplification test; stability; swabs

Mesh:

Year:  2017        PMID: 28077695      PMCID: PMC5328466          DOI: 10.1128/JCM.02235-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2014-03-14

2.  Evaluation of dry and wet transported intravaginal swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by PCR.

Authors:  Charlotte A Gaydos; Kimberly A Crotchfelt; Nina Shah; Marie Tennant; Thomas C Quinn; Joel C Gaydos; Kelly T McKee; Anne M Rompalo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.

Authors:  Julius Schachter; Joan M Chow; Holly Howard; Gail Bolan; Jeanne Moncada
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Community-based chlamydia and gonorrhea screening through the United States mail, San Francisco.

Authors:  Peter J Bloomfield; Charlotte Kent; Diane Campbell; Larry Hanbrook; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2002-05       Impact factor: 2.830

5.  Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.

Authors:  M A Chernesky; D H Martin; E W Hook; D Willis; J Jordan; S Wang; J R Lane; D Fuller; J Schachter
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Azithromycin in control of trachoma.

Authors:  J Schachter; S K West; D Mabey; C R Dawson; L Bobo; R Bailey; S Vitale; T C Quinn; A Sheta; S Sallam; H Mkocha; D Mabey; H Faal
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

7.  Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Barbara Van Der Pol; Oliver Liesenfeld; James A Williams; Stephanie N Taylor; Rebecca A Lillis; Barbara A Body; Mindy Nye; Carol Eisenhut; Edward W Hook
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

8.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

9.  Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.

Authors:  C A Gaydos; T C Quinn; D Willis; A Weissfeld; E W Hook; D H Martin; D V Ferrero; J Schachter
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?

Authors:  Charlotte A Gaydos; Carol Farshy; Mathilda Barnes; Nicole Quinn; Patricia Agreda; Charles A Rivers; Jane Schwebke; John Papp
Journal:  Diagn Microbiol Infect Dis       Date:  2012-05       Impact factor: 2.803

View more
  5 in total

1.  Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status.

Authors:  Sumudu R Perera; Nurul H Khan; Irene Martin; Ali Taheri; Rajinder P Parti; Paul N Levett; Greg B Horsman; Anthony Kusalik; Jo-Anne R Dillon
Journal:  J Clin Microbiol       Date:  2017-08-16       Impact factor: 5.948

Review 2.  Strategies for successful designing of immunocontraceptive vaccines and recent updates in vaccine development against sexually transmitted infections - A review.

Authors:  A S Vickram; Kuldeep Dhama; S Thanigaivel; Sandip Chakraborty; K Anbarasu; Nibedita Dey; Rohini Karunakaran
Journal:  Saudi J Biol Sci       Date:  2022-01-07       Impact factor: 4.052

3.  Testing for Sexually Transmitted Infection Using Wet and Dry Self-Collected Brush Samples Among Women in Mombasa, Kenya.

Authors:  Brigid K Grabert; Jessica Y Islam; Emmanuel Kabare; Nadja A Vielot; Wairimu Waweru; Kishor Mandaliya; Juma Shafi; Lucy Adala; R Scott McClelland; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2021-10-25       Impact factor: 3.868

4.  Evaluation of a Hydrogel-Based Diagnostic Approach for the Point-of-Care Based Detection of Neisseria gonorrhoeae.

Authors:  Sumudu R Perera; Ali Taheri; Nurul H Khan; Rajinder P Parti; Stephanie Stefura; Pauline Skiba; Jason P Acker; Irene Martin; Anthony Kusalik; Jo-Anne R Dillon
Journal:  Antibiotics (Basel)       Date:  2018-08-04

5.  Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus.

Authors:  Cecilia Ferreyra; Jennifer Osborn; Francis Moussy; Emilie Alirol; Monica Lahra; David Whiley; William Shafer; Magnus Unemo; Jeffrey Klausner; Cassandra Kelly Cirino; Teodora Wi
Journal:  PLoS One       Date:  2020-09-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.